Surveillance of CMV Terminase Gene Mutations in Allogeneic Hematopoietic Stem Cell Transplant Recipients Receiving Letermovir Prophylaxis
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.71053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Amandine Caillault und 18 weiteren Autor:innen. Beteiligte Einrichtung: Virology Department, AP-HP, Hôpital Saint Louis, Paris, France. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Cytomegalovirus Infections, Cytomegalovirus, Antiviral Agents. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Letermovir (LMV), a CMV‐specific terminase inhibitor, is recommended for cytomegalovirus (CMV) prophylaxis in CMV‐seropositive allogeneic hematopoietic stem cell transplant (alloHSCT) recipients. The association between low‐level CMV DNAemia during prophylaxis and the emergence of mutations in CMV terminase complex genes remains unclear. We retrospectively analyzed 127 alloHSCT recipients at Saint‐Louis Hospital, Paris, receiving LMV prophylaxis (108 primary, 24 secondary, and 5 both). Weekly CMV DNAemia monitoring was performed, and samples with viral loads ≥ 3 log IU/mL underwent whole‐genome next‐generation sequencing to detect mutations in terminase complex genes. During LMV prophylaxis, CMV DNAemia was detected in 31.5% of primary and 62.5% of secondary prophylaxis patients; however, viral loads ≥ 3 log IU/mL remained low in both groups (8.3%). The frequency of polymorphisms in terminase complex genes increased 2.5‐fold during prophylaxis compared with pre‐prophylaxis, and then decreased 3.0‐fold after prophylaxis withdrawal. Confirmed LMV resistance was found in two patients, representing 1.6% of all patients and 18.2% of those with CMV DNAemia ≥ 3 log IU/mL. Two additional patients harbored mutations at resistance‐associated positions in UL56 and UL89, totaling 36% of patients with viral loads ≥ 3 log IU/mL displaying mutations at known resistance sites. Clinically significant CMV infections were successfully managed with preemptive therapies. This study confirms the efficacy of LMV prophylaxis and demonstrates that LMV exerts selective pressure on the terminase complex, increasing the risk of resistance when CMV DNA levels exceed 3 log IU/mL, underscoring the importance of timely consideration of alternative antiviral therapies when CMV replication persists.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Virology Department, AP-HP, Hôpital Saint Louis, Paris, France.
- Service Hématologie Greffe, Hôpital Saint-Louis, Université Paris Cité, Paris, France.
- Haematology for Adolescents and Young Adults, AP-HP, Hôpital Saint Louis, Paris, France.
- Université Paris Cité, INSERM UMR 1342, Biology and Pathogenesis of Viral Infections, Saint Louis Research Institute, Paris, France.
ORCID-Profile: Flore Sicre de Fontbrune, Pedro Henrique de Lima Prata, Jérôme LeGoff
Zitieren
APA
Caillault, A., Xhaard, A., Mercier-Delarue, S., Feghoul, L., Robert, J., Schnepf, N., Michonneau, D., Robin, M., Sicre de Fontbrune, F., Kaphan, E., Ruggiu-Goiran, M., de Lima Prata, P. H., Chevillon, F., Jestin, M., Dhedin, N., Socie, G., Peffault de Latour, R., Salmona, M., & LeGoff, J. (2026). Surveillance of CMV Terminase Gene Mutations in Allogeneic Hematopoietic Stem Cell Transplant Recipients Receiving Letermovir Prophylaxis. Journal of Medical Virology. https://doi.org/10.1002/jmv.71053
Vancouver
Caillault A, Xhaard A, Mercier-Delarue S, Feghoul L, Robert J, Schnepf N, et al. Surveillance of CMV Terminase Gene Mutations in Allogeneic Hematopoietic Stem Cell Transplant Recipients Receiving Letermovir Prophylaxis. Journal of Medical Virology. 2026. doi:10.1002/jmv.71053
BibTeX
@article{Caillault2026,
author = {Caillault, Amandine and Xhaard, Alienor and Mercier-Delarue, Severine and Feghoul, Linda and Robert, Julien and Schnepf, Nathalie and Michonneau, David and Robin, Marie and Sicre de Fontbrune, Flore and Kaphan, Eleonore and Ruggiu-Goiran, Mathilde and de Lima Prata, Pedro Henrique and Chevillon, Florian and Jestin, Matthieu and Dhedin, Nathalie and Socie, Gerard and Peffault de Latour, Régis and Salmona, Maud and LeGoff, Jérôme},
title = {Surveillance of CMV Terminase Gene Mutations in Allogeneic Hematopoietic Stem Cell Transplant Recipients Receiving Letermovir Prophylaxis},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.71053}
}
EUVIMED